tiprankstipranks
Trending News
More News >
Mayne Pharma Group Ltd. (MAYNF)
OTHER OTC:MAYNF
US Market

Mayne Pharma Group (MAYNF) Financial Statements

Compare
24 Followers

Mayne Pharma Group Financial Overview

Mayne Pharma Group's market cap is currently $159.52M. The company's EPS TTM is $-0.561649235; its P/E ratio is -2.66; Mayne Pharma Group is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 408.10MAU$ 388.15MAU$ 183.59MAU$ 157.15MAU$ 400.78M
Gross ProfitAU$ 247.27MAU$ 218.53MAU$ 26.84MAU$ 23.75MAU$ 127.02M
Operating IncomeAU$ -23.59MAU$ -139.06MAU$ -186.44MAU$ -121.88MAU$ 1.36M
EBITDAAU$ 42.08MAU$ -116.93MAU$ -193.80MAU$ -78.88MAU$ -182.40M
Net IncomeAU$ -93.84MAU$ -174.23MAU$ 117.25MAU$ -281.29MAU$ -208.42M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 100.40MAU$ 149.28MAU$ 220.14MAU$ 97.08MAU$ 98.35M
Total AssetsAU$ 1.01BAU$ 1.14BAU$ 1.25BAU$ 1.30BAU$ 1.48B
Total DebtAU$ 41.27MAU$ 38.82MAU$ 47.51MAU$ 413.67MAU$ 346.82M
Net DebtAU$ -18.57MAU$ -71.25MAU$ -54.21MAU$ 316.59MAU$ 248.47M
Total LiabilitiesAU$ 644.32MAU$ 688.99MAU$ 613.77MAU$ 764.89MAU$ 706.56M
Stockholders' EquityAU$ 370.28MAU$ 454.19MAU$ 634.36MAU$ 545.88MAU$ 768.36M
Cash Flow
Free Cash FlowAU$ 5.19MAU$ -36.16MAU$ -262.71MAU$ -28.47MAU$ 22.16M
Operating Cash FlowAU$ 17.47MAU$ -15.30MAU$ -43.12MAU$ -16.62MAU$ 47.26M
Investing Cash FlowAU$ -68.07MAU$ 53.45MAU$ 473.49MAU$ -28.53MAU$ -49.25M
Financing Cash FlowAU$ -556.00KAU$ -19.85MAU$ -431.48MAU$ 27.60MAU$ -28.83M
Currency in AUD

Mayne Pharma Group Earnings and Revenue History

Mayne Pharma Group Debt to Assets

Mayne Pharma Group Cash Flow

Mayne Pharma Group Forecast EPS vs Actual EPS